Clinical Drug Investigation · 2022 · 14 citations · 49 references
PharmacyNephrologyPharmacoeconomicsCost-effectiveness AnalysisDiabetologyPharmacoeconomic ModelingCost-effectiveness ComparisonDiabetes ManagementDiabetes MellitusDiabetic NephropathyDirect Medical CostsHealthcare Cost AnalysisChronic Disease Cost AnalysisComparative Cost-effectivenessCost-effectivenessDiabetes Medication UsePharmaceutical Cost Analysis
49
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
Vlado Perkovic, Meg Jardine, Bruce Neal et al. · New England Journal of Medicine · 2019 · 6K citations · Full text
Medicine, Nephrology, Pharmacology +17
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J.L. Heerspink, Bergur V. Stefánsson, Ricardo Correa‐Rotter et al. · New England Journal of Medicine · 2020 · 5.2K citations · Full text